Moderna Seeks FDA Authorization For Updated Bivalent COVID-19 Booster Shot

Reuters (8/23, Leo) reports that on Tuesday, Moderna “sought U.S. authorization for its COVID-19 booster shot tailored against the BA.4 and BA.5 subvariants of Omicron and said if cleared it would be ready to deliver the doses in September.” The company’s...